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Department of Chemical and Biomolecular Engineering, University of Akron, Akron, OhioABSTRACT Amyloid-b (Ab) peptides and other amyloidogenic proteins can form a wide range of soluble oligomers of varied
morphologies at the early aggregation stage, and some of these oligomers are biologically relevant to the pathogenesis of Alz-
heimer’s disease. Spherical micelle-like oligomers have been often observed for many different types of amyloids. Here, we
report a hybrid computational approach to systematically construct, search, optimize, and rank soluble micelle-like Ab25-35 struc-
tures with different side-chain packings at the atomic level. Simulations reveal for the ﬁrst time, to our knowledge, that two Ab
micelles with antiparallel peptide organization and distinct surface hydrophobicity display high structural stability. Stable micelles
experience a slow secondary structural transition from turn to a-helix. Energetic analysis coupled with computational mutagen-
esis reveals that van der Waals and solvation energies play a more pronounced role in stabilizing the micelles, whereas the elec-
trostatic energies present a stable but minor energetic contribution to peptide assemblies. Modeled Abmicelles with shapes and
dimensions similar to those of experimentally derived spherical structures also provide detailed information about the roles of
structural dynamics and transition in the formation of amyloid ﬁbrils. The strong binding afﬁnity of our micelles to antibodies
implies that micelles may be a biologically relevant species.INTRODUCTIONThe b-amyloid (Ab), with 39–42 amino acids, is a major
component of neurotic plaques in Alzheimer’s disease
(AD), and its aggregation from unstructured monomers to
b-structured oligomers, elongated protofibrils, and entwined
mature fibrils is believed to play a critical role in the patho-
genesis of AD (1,2). Increasing evidence from numerous
structural determinations and biophysical experiments (3,4)
suggests that soluble and highly ordered Ab oligomers are
likely to be the primary neurotoxic species pathologically
linked to AD. Moreover, these oligomers generally display
distinct structural morphologies (5–8) as a result of structural
differences in peptide size, packing, and sequence, as well as
different environmental conditions. Polymorphism appears
to be a hallmark of amyloid structures, and different
morphologies have been related to various assembly path-
ways to amyloid fibrils, driven by various intermolecular
interactions (9–13).
Ab micelle-like oligomers have been observed by atomic
force microscopy (AFM) and electron microscopy (EM)
(5,14,15), with sizes ranging from 3 nm to 35 nm depending
on the experimental conditions and amino acid sequences
used (14,16). Different sizes of spherical aggregates appear
to be the precursor for fibril nucleation at the very early stage
of aggregation process (17,18), representing different
assembly stages or paths to mature fibrils. It has been sug-
gested that interactions of Ab micelles with other monomers
or oligomers can perturb the micelle state and lead to a struc-
tural transition toward other oligomers with a distinct
morphology (19,20). Of importance, it has been reportedSubmitted February 16, 2010, and accepted for publication May 3, 2010.
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IAPP) can specifically recognize micelle-like oligomers
formed by different amyloidogenic proteins/peptides
(16,21,22), implying that micelle-like oligomers are more
likely to be on-pathway products of fibrillogenesis (18).
Furthermore, studies on the interactions of Ab spherical
particles with the lipid bilayer (23,24) have shown that
spherical Ab oligomers can directly reduce the energy barrier
for ions to pass through the membrane without the formation
of amyloid-pore structures in the cell membrane. Despite
their pathological importance, however, atomic structures
of Ab-micelles are still not available, primarily because of
their small size, short lifetime, and low concentration.
Ab25-35 is an intermembrane domain of APP, and is
thought to be the bioactive and toxic fragment of Ab because
Ab25-35 can form fibrils very quickly in senile plaques and
impair hippocampal neurons in human brains in a manner
similar to that of full-length Ab40/42 (25). Ab25-35 is often
selected as a model system for studying cellular dysfunction,
aggregation, and maladaptive response (26). The short, 11-
residue sequence is more convenient for experimental
synthesis (1,27) and computational simulation (28,29).
Both experimental and computational studies have depicted
many important structural and biological characteristics of
Ab25-35 aggregates. Ma and Nussinov (29) performed molec-
ular-dynamics (MD) simulations to study the free-energy
landscape of Ab25-35 monomers in correlation with their
conformational change. They found that both the a-helix
and the b-strand can contribute to the formation of amyloid
intermediates. using replica exchange MD simulations, Wei
and Shea (28) revealed that the Ab25-35 monomer adopts
a helical structure in apolar organic solvent, and presents
a collapsed coil or, to a lesser extent, a b-hairpindoi: 10.1016/j.bpj.2010.05.006
Ab25-35 Micelle Structures 667conformation in pure water. Of importance, Kaminsky et al.
(30) reported that Ab25-35 can infuse into the lateral ventri-
cles of the brain and increase the p53 level in nuclei from
the neocortex, suggesting that Ab25-35 can affect nuclear
enzyme systems.
In this work, we developed a computational strategy that
includes conformational searches, structural optimization,
potential energy evaluations, and all-atom MD to predict
and model atomic structures of Ab25-35 micelles at a very
early stage of the aggregation process. First, an in-house-
developed peptide packing program, coupled with an
implicit generalized Born with a simple switching function
(GBSW) approach (31), is used to systematically build,
search, and optimize the molecular structure of Ab-micelles
based on the packing energy. The four lowest-energy
micelle-like structures of ~50 A˚ in diameter, consisting
of 62 Ab25-35 peptides, are selected from 2016 candidates
by optimizing interpeptide organizations (i.e., parallel and
antiparallel) and surface hydrophobicity (N-terminus versus
C-terminus) and by further refining the interpetide displace-
ments and intrapeptide self-rotation (Fig. 1). These four pre-
selected micelle-like structures are subsequently subjected to
explicit-solvent MD simulations to examine their structural
stability. Simulations show that the micelles with antiparallel
interpeptide organization display higher structural stability
than those with parallel organization, resulting from the opti-
mization of geometrical side-chain matches among peptides,
surface hydrophobicity, and electrostatic interactions.
A comparative energy analysis shows that peptide-peptide
van der Waals (VDW) interactions and peptide-water solva-
tion interactions are dominant forces for associating peptides
and facilitating secondary structure conversion from turn toFIGURE 1 Three-step strategy for constructing Ab25-35 micelles with
parallel and antiparallel peptide orientations. Step 1: A single peptide is
aligned to the z axis. Step 2: The peptide is replicated and rotated along
the y axis at every 30 to form a semicircle by peptides A–G. The relative
orientation (parallel versus antiparallel) and displacement between adjacent
peptides are adjusted within the semicircle. Step 3: Peptides B–F (but not A
and G) are rotated and copied along the z axis at every 30 to form a micelle
consisting of 62 peptides.helix and, to a lesser extent, b-strand. Molecular docking
of stable micelles with antiamyloid antibodies displays
a high binding affinity, implying that these micelles may
be a biologically relevant species.MATERIALS AND METHODS
Model construction of Ab25-35 micelles
The initial coordinate for monomeric Ab25-35 was generated by averaging
20 NMR-based structures (PDB code: 1QWP, GSNKGAIIGLM) (32) in
a hexafluoroisopropanol/water (80:20) system. This was used as a building
block for micelle construction because Ab monomers are generally more
structurally stable and less aggregated in a hexafluoroisopropanol solution.
Ab25-35 monomer exhibits a well-ordered a-helical structure (residues 28–
34) with a large nonpolar C-terminus and relatively small polar N-terminus
(Fig. S1 in the Supporting Material) possessing a cone shape. The N- and C-
termini were blocked by NH3þ and COO groups, respectively.
In building a compact Ab micelle, we considered the initial relative orien-
tation and position between peptides to be critical factors affecting the final
packing energy and structural stability of the micelles. The interpeptide orien-
tation was chosen to be in either a parallel or an antiparallel orientation, and
the interpeptide position was used to crossly stagger adjacent side chains.
The parallel organization employed two different micelle models: one with
a large nonpolar C-terminus exposed to the solvent, and one with a small polar
N-terminus exposed to the solvent. The antiparallel organization consisted of
one micelle structure with 26 peptides exposing the N-terminus to the solvent
and 36 peptides exposing the C-terminus to the solvent, and versa vice for the
other structure. Thus, based on interpeptide orientation and position, four
basic models were constructed that possessed distinct parallel/antiparallel
organizations and surface hydrophobicity quantified by the ratio of the
number of N-/C-termini exposed on the outer spherical surface.
Fig. 1 shows the three-step procedure involved in building a micelle. First,
a single Ab25-35 peptide is aligned to the z axis at a minimal distance of ~4 A˚
from the origin of the Cartesian coordinate. Second, the peptide is replicated
and rotated along the y axis at every 30 to form a semicircle of seven peptides
(peptides A–G) with the same parallel orientation in the xz plane. Peptides B,
D, and F are rotated an additional 15 along the z axis so that peptides A, C, E,
and G, and peptides B, D, and F are located in different planes. For the anti-
parallel packing, peptides A, C, E, and G are reversed to impose an opposite
orientation relative to peptides B, D, and F. Finally, peptides B–F (but not
A and G) are rotated and copied along the z axis at every 30 to form a micelle
consisting of different circle layers, i.e., B, C, D, E, and F layers. Each layer
consists of 12 peptides, excluding A and G layers, leading to total of 62
peptides in the micelle with initial diameter of ~50 A˚. Four micelle structures
were subjected to coarse structure optimization by using energy minimization
with the GBSW implicit solvent model (31).
For each coarsely-optimized micelle, we further refined the structure by
adjusting the peptide self-rotating angle (F) along the helical axis and
peptide displacement between different layers (l), i.e., each peptide was
rotated along its helical axis at every 15 to avoid side-chain clash while
all neighboring peptides were alternatively shifted along the helical axis
from1.2 to 2.8 A˚ at every 0.2 A˚ (i.e., peptides A, C, E, and G were moved
with respect to peptides B, D, and F along the opposite direction). The struc-
ture-refinement procedure generated 504 distinct structures for each
coarsely-optimized micelle. A total of 2016 wild-type (WT) micelles were
energy-minimized by using 300 steps of steepest descent with backbone
constraint, followed by 200 steps of conjugate gradient and 300 steps of
steepest descent minimization without position constraints in the presence
of the GBSW implicit solvent (31). The four lowest-energy micelles, one
from each category (i.e., parallel organization with all N-termini exposed
to the solvent (P_N), parallel organization with all C-termini exposed to
the solvent (P_C), antiparallel organization with dominant N-termini
exposed to the solvent (AP_N), and antiparallel organization with dominant
C-termini exposed to the solvent (AP_C)) were selected and subjected toBiophysical Journal 99(2) 666–674
668 Yu et al.explicit-solvent MD simulation (Table S1) to examine their structural and
energetic aspects at the early stage of the aggregation process.FIGURE 2 (a) Ab25-35 monomers averaged from the last 5-ns simulations
at 10 ps interval and their structural superimposition with initial NMR model
(blue). (b) Structural comparison of final snapshots of each micelle from MD
simulations. Color: nonpolar residues (red), polar residues (green), and posi-
tively charged residues (blue). Detailed structural evolution of each micelle
is shown in Fig. S4.RESULTS AND DISCUSSION
Conformational search for stable Ab25-35 micelles
The Ab25-35 peptide displays a typical cone shape with
a small hydrophilic N-terminus and a large hydrophobic C-
terminus. Based on four different categories of constructed
micelles, the P_N micelles represent a structural organization
with favorable interface hydrophobicity and unfavorable
geometrical packing because all small, hydrophilic N-
termini are exposed to the bulk solvent. Conversely, the
P_C micelles represent an opposite structural organization
with unfavorable hydrophobic C-termini exposed to the
solvent, but favorable geometrical packing. For the antipar-
allel peptide orientation, the AP_N and AP_C micelles
compromise the packing in geometry and surface hydropho-
bicity. We ensure that each micelle category contains 504
different packings by varying the self-rotating angle (F)
every 15 and the interlayer displacement (l) every 0.2 A˚
along the peptide helical axis. Fig. S2 shows the packing-
energy landscape, calculated by the GBSW method, as
a function of peptide self-rotation and interlayer displace-
ment. Overall, the P_C micelles display the most favorable
average conformational energy (1.7386103 kcal/mol) for
504 candidates, and the P_N micelles show the least favor-
able average conformational energy (1.8587104 kcal/mol).
In similarity to the antiparallel peptide organization, the aver-
aged conformational energy is lower for the AP_C micelles
(4.8967103 kcal/mol) compared to the AP_N micelles
(7.9246103 kcal/mol). This indicates that the geometrical
peptide packing makes a more dominant contribution to
the packing energy.
During the F and l variations, two discrete but similar
energy valleys were observed at F ¼ 75 and 255 for all
micelle categories, suggesting that peptide self-rotation can
largely mediate packing energy by improving the side-chain
geometry match, whereas interlayer displacement can further
reduce packing energy by minimizing side-chain steric colli-
sion. The lowest-energy micelle structure was selected from
504 candidates in each category. The four lowest-energy
micelle structures were identified at F ¼ 210 and l ¼ 1.6 A˚
for the P_N category, F ¼ 45 and l ¼ 0 A˚ for the P_C
category, F ¼ 255, l ¼ 0.8 A˚ for the AP_N category,
and F ¼ 60 and l ¼ 0.4 A˚ for the AP_C category (marked
by a red circle in the packing-energy landscapes; Fig. S2).
Note that it is not feasible to systematically search and opti-
mize >1000 Ab micelles using the explicit-solvent model,
and it could be also problematic to search, compare, and
determine stable Ab micelles among four P_N, P_C,
AP_N, and AP_C categories using the implicit-solvent
model. Thus, we use a two-step strategy to predict the atomic
structures of Ab micelles. We only use the GBSW model to
search for the best candidate within each micelle category,Biophysical Journal 99(2) 666–674instead of choosing the best candidate among four cate-
gories. The four best candidates selected from each category
were further examined for structural stability by means of
all-atom, explicit-solvent MD simulations. Thus, the
lowest-packing-energy structures determined in the GBSW
model are not necessarily the most stable structures in the
explicit solvent due to the lack of hydrogen bonds between
peptides and waters.Structural stability of Ab micelles with a distinct
peptide organization
Visual inspection of the explicit-solvent MD trajectories
shows that both of the micelle structures with a parallel
peptide orientation (i.e., the P_N and P_C models) quickly
lost their initial spherical shape within 8 ns and tended to
transform into elongated, ellipsoidal shapes (Fig. 2 b and
Fig. S4). The deformation is quantified by largely increased
root mean-square deviations (RMSD ¼ 10.5 A˚ for the P_N
model and 11.5 A˚ for the P_C model) and radius of gyration
(Rg ¼ 27.2 A˚ for the P_N model and 28.1 A˚ for the P_C
model; Fig. S3). The structural instability and transition for
both parallel models could be attributed to a charged N-/C-
terminus. Since all charged C- or N-termini are deeply
embedded in the core of the micelle due to the parallel orga-
nization, a strong intermolecular electrostatic repulsion
would tend to push the peptides away from each other. More-
over, unfavorable hydrophobic-water interactions induced
by the hydrophobic C-terminus at the outer surface of the
Ab25-35 Micelle Structures 669P_C micelle, or unfavorable VDW interactions induced by
the large C-terminus embedded inside the P_N micelle could
also unfold the whole micelle structures. All of these effects
can lead to structural instability of parallel micelle structures
in solution. On the other hand, two micelles with antiparallel
peptide organization were able to maintain the overall spher-
ical integrity without peptide disassociation throughout the
44-ns simulations (see detailed snapshots in Fig. S4). Back-
bone RMSDs gradually increased and stabilized at 7.2 A˚ for
the AP_N micelle and 8.3 A˚ for the AP_C micelle, and aver-
aged Rg approached similar values of 24.5 A˚ for the AP_N
micelle and 24.9 A˚ for the AP_C micelle (Fig. S3). Both anti-
parallel micelles were slightly expanded from their initial
energy-minimized structures by optimizing side-chain
contacts. A residue-based root mean-square fluctuation
(RMSF) analysis revealed that both structures showed small
fluctuations for the central residues (Gly29-Ala30-Ile31-Ile32-
Gly33), and large fluctuations for the two terminal residues
and the Lys28 residue (Fig. S3 c), indicating that the charged
residues are more flexible than the neutral residues. In
contrast to the parallel peptide organization, electrostatic
repulsion between the N- and C-termini is partially neutral-
ized via antiparallel peptide packing. Overall, a structural
comparison among the four micelles with distinct parallel
and antiparallel peptide orientations suggests that high struc-
tural stability is a result of a delicate balance among surface
hydrophobicity, geometrical packing, and side-chain
arrangements.
Although both antiparallel micelles displayed relatively
high stability, they also underwent local secondary structure
adjustments to some extent. The population of secondary
structures was averaged and compared between the first
and last 4 ns of the simulation by means of the STRIDE algo-
rithm (33). It can be seen from Table 1 that, although
peptides in the AP_N micelle mainly adopted turn and coil
conformations throughout the 44-ns simulation, all pep-
tides experienced structural conversions for a reduced turn
propensity (54.4% vs. 48.2%), an increased helix propen-
sity (10.1% vs. 14.5%), a slightly increased coil propensity
(34.6% vs. 35.8%), and a similar b-strand propensity
(1.0% vs. 1.5%). A similar tendency for structural transitionTABLE 1 Comparison of secondary structure distributions for
four stable micelles between the ﬁrst and last 4 ns of
a simulation
Model
Time
(ns)
Secondary structure (%)
Turn b-strand Helix Coil
AP_N 0–4 54.4 1.0 10.1 34.6
40–44 48.2 1.5 14.5 35.8
AP_N_K28A 0–4 46.6 2.3 15.8 35.4
40–44 37.6 2.5 21.5 38.5
AP_C 0–4 57.5 1.1 8.8 32.7
40–44 47.3 1.6 15.5 35.7
AP_C_K28A 0–4 49.4 1.2 16.4 33.0
40–44 37.3 1.6 22.6 38.6was also observed for the AP_C micelle, in which turns were
reduced by 10.2% while the helix increased by 6.7%.
It appears that the reduced turn conformation slowly
converts into a helix conformation. Though it is well known
that the cross-b structure is a characteristic conformation in
Ab fibrils formed by either full-length Ab peptides or other
Ab fragments, our simulation shows that the micelles could
exist as stable conformations without the appearance of b-
strands (i.e., <2%) within the 44-ns simulations. This
suggests that the micelles are most likely to appear at the
very early stage of Ab aggregation, serving as a peptide
reservoir to interact with monomers or other low-order olig-
omers to form nuclei seeds or high-order oligomers with
ordered b-structures.Effect of Lys28 on the stability of Ab micelles
Two WT simulations showed that Lys28 residues display
relative large fluctuations in the stable AP_N and AP_C
micelles, presumably due to large electrostatic repulsion.
We performed two additional MD simulations by
substituting the positively charged Lys28 with the Ala
residue for both AP_N and AP_C micelles to examine the
effect of charged residues on the overall structural stability
and the local structural adjustment of the micelles. Visual
inspection of the MD trajectories for both mutants reveals
that, overall, the micelle structures were well maintained
during the 44-ns simulations. The AP_N_K28A mutant
(averaged RMSD ¼ 7.1 A˚) experienced almost the same
structural deviation as the WT of AP_N (RMSD ¼ 7.2 A˚),
and the AP_C_K28A mutant underwent a smaller structural
change (RMSD ¼ 6.7 A˚) than the AP_C (RMSD ¼ 8.3 A˚;
Fig. S3 a and Table S1). Both mutants experienced minor
structural expansion (Fig. S3 b and Table S1), resulting in
more compact spherical structures. The trajectories of these
mutants were further analyzed in terms of individual residue
fluctuations (Fig. S3 c). As expected, the most dramatic
reduction in residue fluctuations occurred at the mutation
site of position 28. A comparison of the RMSD, Rg, and
RMSF data between the WTs and K28A mutants suggests
that the enhanced stability of the mutants is attributed to
the reduction of electrostatic repulsion and the low fluctua-
tions near residue 28.
It is also interesting to monitor the local secondary struc-
ture transition for K28A mutants. As can be seen in Table 1,
although the most populated secondary structure of both
mutants was still the turn conformation, in similarity to the
WTs the reduction in turns concurrently induced the incre-
ment in the a-helix by 5.7% for AP_N_K28A and 6.2%
for AP_C_K28A, and in the coils by 3.1% for AP_N_K28A
and 5.6% for AP_C_K28A. The K28A mutation did not
enhance the formation of b-strand, further suggesting that
unlike other amyloid oligomers, it probably does not need
to contain a large portion of b-structure in the micelle at
the very early stage of aggregation. Fig. 2 a shows sixBiophysical Journal 99(2) 666–674
FIGURE 3 Time evolution of (a) side-chain contacts and (b) hydrogen
bonds between peptides for micelles AP_N (black), AP_C (green),
AP_N_K28A (red), and AP_C_K28A (yellow).
FIGURE 4 (top) Average peptide-peptide interaction energy and (bottom)
peptide solvation energy for AP_N, AP_C, and the corresponding K28A
mutants, calculated by the GBSW method.
670 Yu et al.Ab25-35 monomer structures averaged from each micelle at
10 ps intervals in the last 5 ns of the MD simulations and
their structural superimposition relative to the initial NMR
structure. It can be seen that the average Ab25-35 monomeric
building blocks extracted and averaged from micelles are
very similar to each other; however, these similar monomers
were assembled into micelles displaying different structural
stability and dynamics (Fig. 2 b), emphasizing the impor-
tance of interpeptide interactions in micelle formation.
To quantitatively correlate the structural stability of micelles
with the underlying driving forces upon the mutation of Lys28
to Ala, Fig. 3 shows the time evolution of side-chain contacts
and hydrogen bonds between peptides for four micelles
(AP_N, AP_C, AP_N_K28A, and AP_C_K28A). It can be
seen that all four micelles have a similar number of intermolec-
ular hydrogen bonds between peptides, whereas the WTs
(AP_N and AP_C) have a fewer side-chain contacts than the
mutants (AP_C_K28A and AP_N_K28A). Side-chain
contacts for the WTs decreased in the first ~20 ns and then
remained constant for the rest of the simulations, whereas
side-chain contacts for the mutants experienced subtle changes.
The reduction of these side-chain contacts in WTs compared to
the K28A mutants can be attributed to unfavorable electrostatic
interactions between the Lys28 residues. Moreover, the average
number of side-chain contacts from the last 10 ns was signifi-
cantly larger than the average number of hydrogen bonds, sug-
gesting that interpeptide side-chain contacts are likely to playBiophysical Journal 99(2) 666–674a pronounced role in promoting the formation of micelles,
whereas hydrogen bonds serve to assist the structural conver-
sion to a more ordered b-structure conformation. In previous
studies, Cheon et al. (34) and Auer et al. (35) also observed
that Ab25-35 monomers first coalesced into metastable disor-
dered spherical assemblies driven by hydrophobic interactions
and then converted into b-sheet-rich assemblies driven by
hydrogen bonds. A dynamic interaction network thus plays
an important role in controlling structural conversion and
aggregation pathways among these states.Peptide-peptide and peptide-water interactions
The structural stability and conformational dynamics of Ab
micelles are governed by two energetic contributions from
peptide-peptide interactions and peptide-water interactions.
Fig. 4 shows Ab-Ab peptide interactions with the decom-
posed VDW, and electrostatic contributions and Ab solva-
tion interactions. All interaction energies are averaged at
every 5 ps from the last 5 ns of the simulations using the
GBSW method. Overall, a comparison of the various energy
distributions among the micelles reveals some interesting
common features, as discussed below.
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tion in stabilizing the micelle structures, much more so than
the Ab peptide-peptide interactions. All Ab solvation ener-
gies have very small standard deviations, indicating that
these interactions are very stable, independently of Ab
conformations. Strong solvation interactions are attributed
to the formation of a tightly bound water layer at the micelle
interface, as evidenced by the large number of hydrogen
bonds formed at the surface (HBAP_N ¼ 1019, HBAP_C ¼
918, HBAP_N_K28A ¼ 667, and HBAP_C_K28A ¼ 607) and
the slow self-diffusivity of interfacial waters (~0.385
105 cm2/s; DBulk ¼ 3.37105 cm2/s; Table S3).
However, there is the lack of waters in the interior of the
micelles due to dense side-chain contacts. Waters play
different roles during the different stages of amyloid aggre-
gation, especially before and after formation of a stable
aggregate. Expulsion of waters from peptides is the obliga-
tory first step to facilitate peptide association and subsequent
fibrillization by reducing the free-energy barrier arising from
dehydration entropic effects (36). Once the stable aggregates
form, the highly hydrated water layer around the aggregate
surface helps to prevent peptide disassociation. These results
are in accord with recent experimental (36) and computa-
tional (37) results indicating that solvation energy is an
important driving force for amyloid aggregation.
Second, for the WT micelles, the VDW interactions
clearly played a dominant role in peptide-peptide inter-
actions, contributing all favorable interactions to peptide
association. Burial of the charged residues of Lys28 and
N-/C-terminus was largely compensated for by VDW inter-
actions; hydrophobic interactions among Ala30, Ile31, Ile32,
and Leu33; and some attractive interactions between Lys28
and the C-terminus. However, upon substitution of Lys28
with Ala, electrostatic energy became much more favorable
by decreasing 2957.5 kcal/mol for the AP_N_K28A
micelle and 3584.5 kcal/mol for the AP_C_K28A micelle,
providing additional force to associate Ab peptides. The
neutralization of Lys28 by Ala not only eliminated the unfa-
vorable electrostatic interactions of Lys28-Lys28 buried deep
in the micelle core, enhancing peptide-peptide interactions
from repulsive (positive) forces to attractive (negative)
forces, it also enhanced favorable hydrophobic interactions
with Ala30, Ile31, and Ile32, leading to the increment of
side-chain contacts from ~3400 to ~4000. Despite the elec-
trostatic penalty for WT antiparallel micelles, substantial
stabilizing energy from solvation and VDW interactions
was still retained. Thus, the K28A mutation in Ab25-35
micelles has a limited influence on fibril formation. Karsai
et al. (38) found that WT and Lys28-acetylated Ab25-35
peptides can form structurally similar amyloid fibrils at
a similar aggregation rate. Unlike Ab25-35, substitution of
Lys28 in the full-length Ab40/42 can completely eliminate
intrastrand salt bridges with Asp23 and Glu22, retard the
formation of the b-hairpin motif, and decrease the propensity
for amyloid formation, because the formation of the basicb-strand-turn-b-strand motif with an intact Asp23-Lys28 salt
bridge near the turn is an essential step in full-length Ab fibril
formation. This indicates that amyloid fibril formation by
Ab25-35 or Ab40/42 proceeds through different pathways
and is driven by distinct forces. Thus, aside from well-known
hydrophobic interactions as the driving force of Ab oligo-
merization/fibrillization, Ab micelle formation is a result of
the delicate balance between maximization of favorable
peptide-peptide interactions and optimization of interfacial
water interactions with micelles.Biological implications
Ab aggregates exist in many temporary structural forms,
including a native state, unfolded state, and misfolded inter-
mediate states (39), and spherical soluble oligomers have
been observed for many different types of amyloids (16).
Studies have reported Ab40/42 micelle species consisting of
25–80 Ab monomers with diameters of 30–70 A˚ depending
on the experimental conditions (5,17,24). Unlike the full-
length Ab, Ab25-35 can form micelles immediately after solu-
tion, as shown by AFM and EM images (14,40–43).
However, a detailed structural characterization of these
micelles, including size, number of peptides, and peptide
arrangement, is lacking. Here, we modeled Ab25-35 micelles
of ~55 A˚ consisting of 62 peptides with different peptide orga-
nizations in solution. The formation of stable parallel and anti-
parallel structures by Ab fragments depends on specific
complementary side-chain pairs, hydrogen-bonding patterns,
and favorable hydrophobic and electrostatic interactions.
Because of its inherent spherical morphology, a parallel struc-
ture usually suffers from larger free energy than an antiparallel
structure due to an entropy penalty. It is very unlikely for all
peptides to aggregate into a micelle with the same peptide
orientation. Simulation results showed that for the stable Ab
micelles, the antiparallel orientation between peptides was
more energetically favorable than the parallel orientation.
From an energetic perspective, an antiparallel orientation
can minimize unfavorable electrostatic interactions induced
by charged residues and terminal residues, whereas from an
entropic perspective, it seems unlikely that all peptides will
pack in the same parallel way during the assembly process,
as opposed to random orientation. Our antiparallel models
present the most favorable situation in terms of free energy.
Moreover, we examined two additional antiparallel micelles
(AP_N with F ¼ 75 and l ¼ 1.6 A˚, and AP_C with
F ¼ 255 and l ¼ 0.6 A˚) and two parallel micelles (P_N
with F ¼ 60 and l ¼ 1.2 A˚, and P_C with F ¼ 360 and
l ¼ 0 A˚) selected from the energy landscape (Fig. S2). Both
of the antiparallel structures consistently displayed similar
high structural stability within 40 ns, whereas the parallel
structures transformed into nonspherical shapes within 8 ns
(Fig. S5). Cheon et al. (34) studied the early stage of the
Ab16-22 and Ab25-35 oligomerization process using Monte
Carlo simulations. They found that both sequences couldBiophysical Journal 99(2) 666–674
FIGURE 5 Six micelles (gray) obtained from the peptide-packing
program and MD simulations were docked to a Fab region of the antiamyloid
antibody (PDB: 3BAE). Unstable micelles with parallel peptide organization
(a and b) generally have smaller binding energy than stable micelles with
antiparallel peptide organization (c–f).
FIGURE 6 Schematic model for Ab fibrillogenesis involving different Ab
aggregates and pathways during the aggregation process.
672 Yu et al.quickly coalesce into spherical aggregates with no significant
b-structure present, followed by structural reorganization into
a single-layer b-sheet. A similar two-step oligomerization
from disordered micelles to ordered b-sheets via a coales-
cence-reorganization mechanism was further confirmed by
Auer et al. (35). Consistent with our micelle models, at the
initial coalescence step, all peptides in the micelles are not
organized in a parallel manner. Moreover, a number of studies
have shown an antiparallel b-sheet orientation for double-
layer Ab40/42 linear oligomers and annular oligomers (44–46).
The fact that micelles or spherical aggregates of various
sizes are often observed by AFM and EM during the very
early stage of amyloid fibrillization, and then disappear as
the nucleus or fibrils form (5), indicates that these micelles
are intermediates in the pathway to fibril formation. Due to
the early appearance and transitory nature of micelles,
micelle structures do not necessarily adopt characteristic
b-structures; rather, they show a mixture of a-helix, random
coil, and extended conformations. Our micelle models
possessed a mixture of turn, coil, helix, and b-strand confor-
mations. Although only a small portion of b-structure was
present in the micelles, a slow trend from turn to a-helix
was observed. Using transmission EM and solid-state
NMR, Chimon and co-workers (15) found that the formation
of spherical intermediates (5–35 nm in diameter) required an
assembly procedure from Ab monomers to spherical aggre-
gates with random Ab conformation to spherical intermedi-
ates with high b-sheet structure. Chebaro et al. (47) found
that Ab16-35 monomers and dimers were dominated by coil
and turn conformations with little b-sheet structure.
Several studies on Ab aggregation have revealed that Ab
micelles have a high binding affinity to the antibody. It is
generally accepted that if the Ab oligomer has a strong binding
affinity to the antibody, it may be a more biologically relevant
(toxic) species, because only toxic species can be specifically
recognized by the antibody. To identify the biological rele-
vance of our micelle models, we docked six micelles to an anti-
amyloid antibody (PDB: 3BAE) (48) using Patchdock (49)
and Firedock (50). The docking results (Fig. 5) showed that
the antibody displayed a higher binding affinity for stable
micelles with antiparallel organization (AP_N and AP_C)
than for two unstable micelles with parallel peptide organiza-
tions (P_N and P_C; Fig. 5). This is consistent with experi-
mental data (16,24) indicating that all spherical oligomers
from Ab, a-synuclein, IAPP, polyQ, and prion106-126 can
be specifically recognized by the antibody and induce
a dramatic increase in membrane conductance. We note that
these micelles can also be converted into other protofibrils/
fibrils with varied morphologies over time when in equilib-
rium with Ab monomers and/or oligomers.
Given these experimental and computational findings, we
propose a general model to describe the sequence of assembly
along with different aggregates of monomers, micelles,
nucleus, and fibrils (Fig. 6). Ab monomers can quickly aggre-
gate into compact micelles driven by hydrophobic interactionsBiophysical Journal 99(2) 666–674at the very early stage of aggregation (a/b), as observed in
many AFM and EM images. These amorphous micelles can
serve as a reservoir to interact with other species and slowly
transform into ordered b-structure-rich oligomers with
different structural morphologies (b/c), followed by a fast
growth process for peptide elongation and protofibril lateral
association to mature fibrils (c/d). Alternatively, Ab mono-
mers can also form small oligomers directly, not via the
micelle state (a/c). This procedure corresponds to a slow
lag phase for seed formation. Since both of these hypothetical
pathways lead to final fibrils, they are not mutually exclusive.
CONCLUSIONS
Ab micelles are often observed during the early stage of
amyloid formation; however, because of their small sizes
Ab25-35 Micelle Structures 673and transitory nature, their atomic structures and the biolog-
ical role they play in amyloid aggregation and toxicity are
still unclear. In this work, we used an in-house-developed
peptide-packing program coupled with explicit-solvent MD
simulations to predict, model, and validate the atomic struc-
tures of Ab micelles by optimizing side-chain packing
(orientation and displacement) and interfacial hydropho-
bicity. The MD simulations demonstrate the existence of
stable Ab micelles with an antiparallel peptide organization
in solution, which undergo an early and slow conformation
change from turn to a-helix. It is unlikely for peptides to
be organized in a parallel manner to form a micelle, due to
the high entropy penalty and large, unfavorable charge repul-
sion. An energetic comparison among all micelle models
also reveals that the high structural stability of Ab micelles
originates from competitive Ab-Ab and Ab-water interac-
tions involving the surface hydrophobicity of the Ab micelle,
interior interpeptide packing, and the structure and dynamics
of the interfacial waters. Moreover, given their strong
binding affinity to the antibody, these stable micelles may
be biologically relevant species. Two stable WT micelles
with different packing structures also suggest distinct inter-
mediates during the aggregation process. On the other
hand, it behooves us to emphasize that simulations cannot
afford to explore all possibilities for micelle structures, due
to the limited sampling spaces. Other structural possibilities
for micelles are not excluded by our Ab25-35 micelles. This
work provides quantitative biophysical insights into the
formation of Ab micelles during the early stage of the aggre-
gation process, and its implications for the transformation
into mature fibrils.SUPPORTING MATERIAL
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